Published April 28, 2026
| Version v1
Preprint
Open
GRIN Receptor Antagonism for Pain Management in SCD
Description
Multiple GRIN genes (GRIN1, GRIN2A/B/D, GRIN3A/B) show 0.36 association scores with SCD (Open Targets). These encode NMDA receptor subunits involved in pain signaling. Selective GRIN2B antagonists could provide targeted pain relief without addiction risk, addressing the high opioid use in SCD (PharmGKB shows CYP2D6 variants affect opioid response in Nigerian SCD patients).
Notes
Files
hypothesis.json
Files
(327 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:2748b871d5920f398e2c1f9b94bae9d5
|
327 Bytes | Preview Download |